Biomarin Pharmaceuticals (BMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2005 | 06-2005 | 03-2005 | 12-2004 | 09-2004 | |
Sales | 7,579 | 3,626 | 4,989 | 13,897 | 181 |
Cost of Goods | 164 | 478 | 660 | 3,305 | 35 |
Gross Profit | 7,415 | 3,148 | 4,329 | 10,592 | 146 |
Operating Expenses | 24,141 | 25,703 | 26,505 | 91,455 | 26,296 |
Operating Income | -16,562 | -22,077 | -21,516 | -80,558 | -26,115 |
Interest Expense | 2,863 | 2,940 | 3,259 | 3,326 | 3,429 |
Other Income | 3,949 | 3,677 | 2,317 | 1,462 | 66 |
Pre-tax Income | -15,476 | -21,340 | -22,458 | -82,422 | -29,478 |
Net Income Continuous | -15,476 | -21,340 | -22,458 | -82,422 | -29,478 |
Net Income | $-15,476 | $-21,340 | $-22,458 | $-82,422 | $-29,478 |
EPS Basic Total Ops | -0.21 | -0.33 | -0.35 | -1.28 | -0.46 |
EPS Basic Continuous Ops | -0.22 | -0.33 | -0.35 | -1.28 | -0.46 |
EPS Diluted Total Ops | -0.21 | -0.33 | -0.35 | -1.28 | -0.46 |
EPS Diluted Continuous Ops | -0.22 | -0.33 | -0.35 | -1.28 | -0.46 |
EBITDA(a) | $-14,133 | $-19,672 | $-19,050 | $-74,799 | $-23,959 |